Stocks should rally if the U.S. and China agree to new negotiations and a ceasefire in the trade war, but the economic impact of tariffs will continue.Market Insiderread more
Democrats want Mueller's testimony on his probe into Russian interference in the 2016 election and Trump's efforts to influence it.Politicsread more
The trade war between Beijing and Washington appears to have depressed Chinese property purchases in the United States. China's own actions may also be playing a role.Real Estateread more
Tesla CEO Elon Musk sent out another email to his employees, pushing them to aim for a record number of vehicle deliveries to end the second quarter of 2019.Technologyread more
More than 300 companies are talking to government officials in Washington about how detrimental the trade war is.Marketsread more
Powell stresses the central bank's independence in a speech that comes amid continuous pressure from the White House to cut interest rates.The Fedread more
The Senate is expected to pass its own version of the border aid legislation, while the Trump administration has threatened to veto both bills.Politicsread more
Markets in Asia fell on Wednesday morning after U.S. Federal Reserve Chairman Jerome Powell tempered expectations for a potential interest rate cut.Asia Marketsread more
The purchase confirms Apple's continued interest in self-driving car software, and it will bolster Apple's engineering ranks with additional employees who can build autonomous...Technologyread more
More than 1,000 protesters marched to major foreign consulates on Wednesday calling on leaders at the upcoming G-20 summit to raise the plight of Hong Kong with China and to...World Politicsread more
In a text message, Grisham confirmed to CNBC that she will still be working for the first lady even as she takes on her new roles.Politicsread more
The "selfie generation" could be even more of a needle-mover than you thought, at least according to Allergan Chairman, President and CEO Brent Saunders.
Of the 30 million people in the United States who consider getting aesthetic treatments like Allergan's Botox, only three million people actually follow through with getting the procedures.
But within that three million, "we see two new groups that are starting to emerge: millennials, which only account for maybe 10, 15 percent of the three million, and males, which also probably account for 10, 15 percent," Saunders told "Mad Money " host Jim Cramer on Monday.
Both millennials and males are relatively new to the aesthetic application space, but the groups are growing rapidly, the CEO said.
"So, yes, maybe the selfie generation has a lot to do with this," Saunders told Cramer.
Allergan has made a concerted push into the medical aesthetics space, its recent $2.48 billion acquisition of Zeltiq being the biopharmaceutical giant's latest move.
Allergan will add Zeltiq's signature body-contouring technology known as CoolSculpting to its list of aesthetic offerings, which also include Kybella, an injectable double-chin treatment.
Despite rumblings that Allergan's management was disappointed with Kybella's performance, Saunders assured Cramer that the treatment works, it will just take time to develop.
"We are creating a new market – the lower face," Saunders said. "It takes some time. It took us a long time to develop the upper face, several years. CoolSculpting, for fat reduction, it's been around six, seven years. We just hit somewhere around four, five million treatments. We're just hitting our stride. These new markets take a few years to develop. We should be patient. But Kybella works, it delivers exactly as the label indicates, and the injectors are getting comfortable with it."